CARTIA

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

ACETYLSALICYLIC ACID

Tersedia dari:

PADAGIS ISRAEL AGENCIES LTD, ISRAEL

Kode ATC:

B01AC06

Bentuk farmasi:

TABLETS ENTERIC COATED

Komposisi:

ACETYLSALICYLIC ACID 100 MG

Rute administrasi :

PER OS

Jenis Resep:

Not required

Diproduksi oleh:

ASPEN PHARMA PTY LTD, AUSTRALIA

Kelompok Terapi:

ACETYLSALICYLIC ACID

Area terapi:

ACETYLSALICYLIC ACID

Indikasi Terapi:

The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Tanggal Otorisasi:

2020-09-30

Selebaran informasi

PATIENT PACKAGE INSERT IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS)
– 1986
The medicine is dispensed without a doctor’s
prescription
CARTIA
TM
ENTERIC-COATED TABLETS 100 MG
EACH TABLET CONTAINS:
ACETYLSALICYLIC ACID 100 MG.
Inactive and allergenic ingredients in the preparation:
see section 2 “Important information about some
of the ingredients of the medicine” and section 6
“Further information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE
USING THE MEDICINE.
This leaflet contains concise information about the
medicine. If you have further questions, refer to the
doctor or pharmacist.
Take the preparation according to the dosage
instructions in section 3. Consult the pharmacist if
you need additional information.
1.
WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for primary prevention
of coronary heart disease in patients at increased
risk and secondary prevention of heart and brain
diseases caused by arterial thrombosis.
THERAPEUTIC GROUP: anticoagulant, platelet
aggregation inhibitor.
Cartia inhibits the aggregation of blood platelets and
in this way prevents blood clots from developing.
2.
BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
• You are sensitive )allergic( to acetylsalicylic
acid )the active ingredient(, salicylates or to any
of the additional ingredients contained in the
medicine )see section 6 “Further information”(.
•
You have had a reaction in the past to certain
medicines for pain, fever or inflammation
)salicylates
or
other
non-steroidal
anti-inflammatory drugs(, which manifested
by asthma attacks or other allergic reactions.
•
You suffer from acute gastric or intestinal ulcers.
• You have a tendency to disorders leading to
bleeding.
•
You suffer from kidney or liver failure.
•
You suffer from severe heart failure which is not
being adequately treated.
•
You are concurrently taking methotrexate at a
dosage of 15 mg or more per week.
•
You are in your last trimester of pregnancy and
are taking a daily dosage above 150